Lineage Cell Therapeutics, Inc. (LCTX)
1.70
+0.05
(+3.03%)
USD |
NYAM |
Jan 16, 16:00
1.705
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Market Cap: 391.56M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 527.82M |
| Belite Bio, Inc. | 5.819B |
| ProKidney Corp. | 324.14M |
| CEL-SCI Corp. | 15.63M |
| AIM ImmunoTech, Inc. | 3.942M |
Market Cap Related Metrics
| PS Ratio | 35.51 |
| PEG Ratio | -0.0338 |
| Price to Book Value | 17.77 |
| Price | 1.70 |
| Earnings Yield | -17.45% |
| PEGY Ratio | -0.0338 |